Report
Sickle Cell Disease Treatment Demonstration Program Congressional Report 2014
Recommendations for improving care for people with sickle cell disease.
This report to Congress synthesizes the results and recommendations of four years of the Sickle Cell Disease Treatment Demonstration Program (one part of NICHQ’s Working to Improve Sickle Cell Healthcare project).
The Congressional Report recommendations address several different levels of action:
- Recommendations for clinical delivery and public health programs
- Recommendations for the design or re-design of the Sickle Cell Disease Treatment Demonstration Program
- Recommendations for broad health policy
SCDTDP Congressional Report Oct 2014 - Full Report
|
PDF
|
3 MB
SCDTDP Congressional Report Oct 2014 - Executive Summary
|
PDF
|
583 KB
SCDTDP Model Protocol Oct 2014
|
PDF
|
6 MB
Details
Date published:
October 13, 2014
Authors:
Bill Adams, MD, Professor of Pediatrics, Boston University School of Medicine; Director of Clinical Research Informatics, Boston University Clinical and Translational Science Institute
Elissa Faro, PhD, Senior Research and Knowledge Manager, NICHQ
Patricia Finnerty, MPH, Associate Project Director, NICHQ
Charlie J. Homer, MD, MPH, Chief Executive Officer and Project Executive, NICHQ
Elisa Mai, Project Manager and Grant Specialist, NICHQ
Amanda Norton, MSW, Improvement Advisor
Suzette Oyeku, MD, MPH, Strategic Project Director, NICHQ; Associate Professor of Clinical Pediatrics, Albert Einstein College of Medicine
Rachel Vanderkruik, MSc, Analyst, NICHQ
C. Jason Wang, MD, PhD, Associate Professor of Pediatrics, Director of Center for Policy, Outcomes, Prevention, Stanford School of Medicine